The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
C
|
Cummins Inc
XMUN:CUM
|
US |
|
Y
|
Yip's Chemical Holdings Ltd
OTC:YIPCF
|
HK |
|
Tosei Corp
TSE:8923
|
JP |
|
F
|
FTI Consulting Inc
F:FCQ
|
US |
|
One Stop Systems Inc
NASDAQ:OSS
|
US |
|
C
|
C Sun Mfg Ltd
TWSE:2467
|
TW |
|
Y
|
Yokogawa Electric Corp
F:YKE
|
JP |
|
Cimsa Cimento Sanayi ve Ticaret AS
IST:CIMSA.E
|
TR |
|
M
|
Miss Grand International PCL
SET:MGI
|
TH |
|
C
|
China Travel International Investment Hong Kong Ltd
F:CTI
|
HK |
|
UMS Integration Ltd
SGX:558
|
SG |
|
K
|
Kyowa Leather Cloth Co Ltd
TSE:3553
|
JP |
|
Aurora Cannabis Inc
F:21P
|
CA |
|
E
|
Evoke PLC
OTC:EIHDF
|
GI |
Myriad Genetics Inc (MYD)’s 12-month stock price forecast through November 2027 has a consensus target of €5.098, implying 9% downside. The forecast is based on price targets from 11 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
MYD is 5.098 EUR with a low forecast of 2.744 EUR and a high forecast of 9.128 EUR.
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 4%.
Over the last 4 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 4 years is 4%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more